# FDA 483 - New York Blood Center Inc - May 01, 2018

Source: https://www.keypedia.com/records/483/new-york-blood-center-inc/d0dc4e9a-23cc-4a9c-baef-c8ec47f982fe

> FDA 483 for New York Blood Center Inc on May 01, 2018. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: New York Blood Center Inc
- Inspection Date: 2018-05-01
- Product Type: biologics
- Office Name: Division of Human and Animal Food Operations - East I
- Summary: New York Blood Center Inc, a donor center in Massapequa, NY, was cited for two observations during an FDA inspection. The findings include failure to maintain proper storage temperatures for platelets and not consistently following written standard operating procedures for blood component collection. These issues indicate potential deficiencies in quality control and adherence to established protocols for blood product handling.

## Related Documents

- [483 - 2021-02-24](https://www.keypedia.com/records/483/new-york-blood-center-inc/46a7dfcb-fdde-4e76-8556-ca7167ebde3a)

## Related Officers

- [Investigator](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)

Company: https://www.keypedia.com/companies/new-york-blood-center-inc/ffed078a-99a5-4934-961a-8262fee09c76

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-east-i/a807f00e-d780-40b8-b233-1eb92ece8961